Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-11-09 | "Mr. Loughlin brings to the board his valuable experiences as National Director of the Pharmaceuticals Practice at KPMG LLP, an extensive background in accounting and financial reporting..." |
| 2013-11-07 | "Mr. Loughlin brings to the board his valuable experiences as national director of the pharmaceuticals practice at KPMG LLP, an extensive background in accounting and financial reporting" |
| 2014-10-27 | "Mr. Loughlin brings to the board his valuable experiences as the former national director of the pharmaceuticals practice at KPMG LLP, an extensive background in accounting and financial reporting" |
| 2015-07-29 | “Mr. Loughlin served as the national director of the pharmaceuticals practice at KPMG LLP” |
| 2016-05-04 | "Mr. Loughlin brings to the board his valuable experiences as national director of the pharmaceuticals practice at KPMG LLP, an extensive background in accounting and financial reporting..." |
| 2017-08-29 | “James J. Loughlin(4)” ... “Mr. Loughlin resigned from our board of directors as of May 24, 2016.” |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04